|
|
Article: Advanced Viral Research Corp. Announces Retention of James T. D'Olimpio, MD As 'Spokesperson at Large'.
- Article from:
- PR Newswire
- Article date:
- November 18, 2003
CopyrightCOPYRIGHT 2003 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Advanced Viral Research Corp. (BULLETIN BOARD: ADVR) today announced the retention of James T. D'Olimpio M.D., as the Company's "Spokesperson at Large." In this new role, Dr. D'Olimpio will assist the Company in bridging the information gap between the investment community and the medical community in areas surrounding the further development and maturation of clinical trials of AVR118 (formerly known as Product R). In addition to this consulting role, Dr. D'Olimpio will continue as a member of the Company's Scientific Advisory Board.
Eli Wilner, Chairman of the Company's Board said, "Jim has assisted the Company in the clinical development of AVR118, ...
Related newspaper, magazine, and journal articles:
|
|
Article: Advanced Viral Research Corp. Receives Approval in ...
Business Wire;
February 18, 2000 ;
700+ words
... ... application to the FDA. The Advanced Viral Research Institute also is ... based therapeutics. About Advanced Viral Research Corp. Advanced Viral Research Corp., based in Yonkers, New York, is a biopharmaceutical ...
|
|